NCT06119113 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Ekin M, Dagdeviren H, Caypinar SS, Erdogan B, Ayag ME, Cengiz H, Yasar L, Helvacioglu C
Comparative cosmetic outcome of surgical incisions created by the PEAK Plasma Blade and a scalpel after cesarean section by Patient and Observer Assessment Scale (POS
Fleisher J, Khalifeh A, Pettker C, Berghella V, Dabbish N, Mackeen AD
Patient satisfaction and cosmetic outcome in a randomized study of cesarean skin closure. J Matern Fetal Neonatal Med. 2019 Nov;32(22):3830-3835. doi: 10.1080/14767058.2018.1474870. Ep
Yang J, Kim KH, Song YJ, Kim SC, Sung N, Kim H, Lee DH
Cosmetic outcomes of cesarean section scar; subcuticular suture versus intradermal buried suture. Obstet Gynecol Sci. 2018 Jan;61(1):79-87. doi: 10.5468/ogs.2018.61.1.79. Epub 2018 Jan 9.

Evaluation of Wound Site Infection, Early and Late Wound Healing and Cosmetic Results of Vicryl, Tekmon and Prolene Suture Materials Used in Pfannenstiel Skin Incision in Caesarean Section Surgery

Details for clinical trial NCT06119113

Clinical trial NCT06119113 - References